Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy

Maturitas
M O SatorJ C Huber

Abstract

To show the reducing effect of estrogens and progestins on the elevated intraocular pressure (IOP) in the case of a 56-year-old woman showing typical climacteric complaints, who was admitted to the menopause outpatient unit. She also suffered from a primary open-angle glaucoma treated with betaophtiole eye drops with intraocular pressures of 16-20 mmHg under this local therapy. IOP patterns were monitored by means of standardised daily pressure profiles four times a day before as well as 4 and 12 weeks after the beginning of hormone replacement therapy (HRT). The local glaucoma therapy remained unchanged. During HRT, IOP levels were reduced from 16-20 mmHg before therapy to 12-15 mmHg at week 4 and to 13-15 mmHg at week 12 after the beginning of HRT. The finding of a close chronological relationship between the onset of menopause and the development of a glaucoma is a potentially new indication for HRT.

References

Jan 1, 1994·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·N M Guttridge
Dec 10, 1997·Maturitas·M O SatorJ C Huber

❮ Previous
Next ❯

Citations

Oct 19, 2006·Archives of Gynecology and Obstetrics·Fatma Ferda VeritOmer Bozkurt
Oct 22, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Miguel Coca-PradosPirkko Vihko
Feb 15, 2001·Maturitas·C WordaM O Sator
Jan 29, 2003·Journal of Cataract and Refractive Surgery·Xiao-Hong ZhangJia-Qin Yuan
Sep 23, 2003·Menopause : the Journal of the North American Menopause Society·Pietro AffinitoCarmine Nappi
Jan 13, 2004·Menopause : the Journal of the North American Menopause Society·Cesare BattagliaDomenico De Aloysio
Sep 23, 2009·Menopause : the Journal of the North American Menopause Society·Naing L TintAugusto Azuara-Blanco
Mar 15, 2012·Menopause : the Journal of the North American Menopause Society·Thasarat S Vajaranant, Louis R Pasquale
Feb 15, 2002·American Journal of Veterinary Research·Ron OfriLaurence S Shore
Sep 26, 2013·Menopause : the Journal of the North American Menopause Society·Thasarat S VajaranantWalter A Rocca
Jul 2, 2005·Journal of Glaucoma·Yoram AbramovEyal Banin
Jan 7, 2010·Current Opinion in Ophthalmology·Thasarat S VajaranantCharlotte E Joslin
Jun 16, 1999·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·D M Gruber, J C Huber
Oct 31, 2006·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Gürkan UncuOsman Develioğlu
Feb 2, 2011·Climacteric : the Journal of the International Menopause Society·H CoksuerC Coksuer
Mar 5, 2016·American Journal of Ophthalmology·Thasarat S VajaranantMary N Haan
Apr 20, 2007·Developmental Neurobiology·Xiaohong ZhouWei Cao
Aug 9, 2005·American Journal of Ophthalmology·Barbara A FinkKarla Zadnik
Nov 25, 2003·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Kaori KobayashiSatoshi Okinami
Feb 21, 2018·Scientific Reports·Xiaomin ChenDavid A Sullivan
Jun 14, 2019·Fukushima Journal of Medical Science·Sakumi KazamaNoburo Ando
Sep 15, 2020·Investigative Ophthalmology & Visual Science·Mark J SimcoeUNKNOWN UK Biobank Eye and Vision Consortium
Jul 24, 2020·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M-A Gamulescu
Oct 12, 2020·Cellular and Molecular Neurobiology·Kyrylo FoteskoRupali Vohra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.